USMJ WITH PURA AND NFL CHICAGO BEARS LEGEND JIM McMAHON PROMOTE CANNABIS PAIN MANAGEMENT AND CTE CONCUSSION TREATMENT

Dallas, TX – June 17, 2016 – North American Cannabis Holdings, Inc. (USMJ) and Puration, Inc. (PURA) with two time Super Bowl quarterback champion Jim McMahon are together promoting cannabis as a superior pain management resource and a promising treatment for CTE.  The three were together yesterday at the Cannabis World Congress & Business Exhibition at the Javits Center in New York City.  USMJ and PURA are together introducing a line of sports and fitness cannabis infused supplements in keeping with the advocacy agenda they are promoting with Jim McMahon. The conference is continuing today.

“I’m here because I believe in the plant,” McMahon said. “They keep calling it a drug.  It’s a medicinal herb.  To Me, it’s better for you than the pills I was eating for so many years.”

USMJ and Jim McMahon, former quarterback with the Chicago Bears and Green Bay Packers and two time Super Bowl Champion, earlier this year announced the the formation of the Cannabis Sports Policy Project (CSPP).  Working together strategically with USMJ to introduce a line of cannabis infused sports and fitness supplements, PURA is the first CSPP sponsor.

Jim McMahon is an advocate for medical marijuana.  As a result of injuries incurred while playing in the NFL, he has endured 18 surgeries and now lives with chronic pain.  Medical marijuana has enabled McMahon to end a pharmaceutical pain killer habit.

The Cannabis Sports Policy Project is founded by USMJ, but operates separate from USMJ to raise awareness for the benefits of medical marijuana over pharmaceutical pain killers in the management of pain from injuries incurred by athletes in addition to raising awareness for the potential of medical marijuana to mitigate the long-term damage that can result from repetitive head trauma.  The Cannabis Sports Policy Project will also raise funds to advocate for pro cannabis policy changes within sport governing bodies.

North American Cannabis Holdings is an entrepreneurial cannabis consumer products development company founded on the belief that cannabis makes lives better.  Cannabis can fight disease and improve wellness.  

In addition to other cannabis infused consumer product lines, USMJ leads a business partnership that includes PURA and a registered not-for-profit called Nature Comfort Meds (NCM) which holds a United States patent for medical marijuana and hemp cannabis extraction.  Research and development efforts with the patented process have resulted in positive benefits for treating illnesses including veterans suffering from PTSD, children with autism, various types of cancer, patients with a variety of neurological disorders, pain management, auto-immune disorders and seizures due to Epilepsy.  The three Companies, USMJ, PURA and NCM are all working to solidify plans for a commercial application of the patented extraction process.

NaturesComfortMeds.org 

Headquartered in Providence, RI, Natures Comfort Meds (NCM) is dedicated to cutting edge research and development using various strains of the cannabis plant and extracting oils utilizing their patented process. Utilizing proprietary methods for botanical extraction, NCM leads the industry in being able to produce highest quality products, currently testing various strains of medicinal plants for use in clinical studies with various partners.

Learn more about Puration, Inc. and keep up to date on the rapid changes anticipated throughout 2016 on the Company's website: http://www.purationinc.com/

About North American Cannabis Holdings, Inc.

North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. For more information please visit http://www.growusmj.com.

Follow the company on Twitter: https://twitter.com/US_HEMP.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

Contact:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com